Farmae S p A : TWO LISTS WERE FILED FOR THE APPOINTMENT OF THE BOARD OF STATUTORY AUDITORS AND A PROPOSAL FOR A RESOLUTION CONCERNING THE REMUNERATION TO BE PAID TO THE NEWLY APPOINTED AUDITORS

Press Release

TWO LISTS WERE FILED FOR THE APPOINTMENT OF THE BOARD OF STATUTORY

AUDITORS AND A PROPOSAL FOR A RESOLUTION CONCERNING THE REMUNERATION TO BE PAID TO THE NEWLY APPOINTED AUDITORS

Viareggio, April 24, 2021 - Farmaè S.p.A. - a company listed on the AIM Italia market of the Italian Stock Exchange, leader in Italy in the e-retailing of health and wellness products - (the "Company") announces that yesterday, with reference to the Ordinary Shareholders' Meeting of the Company convened for April 30, 2021, the following two lists of candidates for the appointment of the Board of Statutory Auditors 2021-2023 and, specifically: the appointment of the Acting Auditors, of the Alternate Auditors and the appointment of the Chairman of the Board of Statutory Auditors were deposited within the statutory terms.

List no. 1 - presented by Riccardo Iacometti, who directly holds 70% of the Company's share capital, as follows:

Acting Auditors

1. Mr. Alberto Colella (Chairman of the Board of Statutory Auditors)
2. Mr. Marco Guidi
3. Mrs. Monica Barbara Baldini

Alternate Auditors

1. Mr. Fabio Panicucci
2. Mr. Massimo Mano

List no. 2 - presented by Indaco Venture Partners SGR S.p.A., which holds 2.716% of the Company's share capital, and Equilybra S.p.A., which holds 2.319% of the Company's share capital (Indaco Venture Partners SGR S.p.A and Equilybra S.p.A. therefore jointly hold 5.035% of the Company's share capital) - composed as follows:

Acting Auditors

1. Dott. Sergio Marchese

Alternate Auditors

2. Dott. Gian Luca Succi

It should be noted that the shareholders who submitted list no. 2 declared the absence of any connection with shareholders holding a controlling interest, pursuant to art. 144-quinquies of the Issuers' Regulation.

***

Yesterday, the shareholder Riccardo Iacometti also filed his resolution proposal with regard to the remuneration to be granted to the newly appointed Auditors.

1

***

The above-mentioned lists, together with the supporting documents, and the proposed resolution concerning the remuneration to be awarded to the newly appointed auditors are available to the public at the Company's registered office and on the Company's website www.farmaegroup.it (Governance/Shareholders' Meetings section).

This press release is available in the Investor Relations section and on the Company's website at www.farmaegroup.it.

***

Born in Viareggio in 2014 Farmaè is the first OnLife eRetailer of Health and Wellness in Italy. "OnLife" retail is a new economic paradigm, characterized by the integration of online, offline, logistics and data in a single value chain. Today the company operates mainly in eCommerce with more than 45,000 references in 14 different product categories marketed, but it is also present in the country with 9 Farmaè and 1 Beautyè Store. In sharing the new philosophy "OnLife", Farmaè intends to put the customer at the center of its circular activities, responding immediately, quickly and pragmatically to every need and ensuring a unique customer experience, regardless of the purchase channel used.

For further information:
Nomad	Specialist
Alantra Capital Markets	Banca Profilo S.p.A.
[phone]	[phone]
Stefano Bellavita	Alessio Muretti
[e-mail]	[e-mail]

Investor Relation	Media Relation
Farmaè	SEC Newgate - 02.624.999.1 - [e-mail]
Investor Relations Officer	Laura Arghittu [e-mail]
Alberto Maglione	Federico Ferrari - 347 6456873 - [e-mail]
[phone]	Daniele Pinosa - 335 7233872 - [e-mail]
[e-mail]	Fabio Santilio - 339 8446521 [e-mail]
CDR Communication srl
IR Advisor
Vincenza Colucci
Tel. [phone]
[e-mail]

2